Enhancing data integrity & aseptic manufacturing compliance

挑战

With the introduction of the new European Medical Device Regulation (MDR), the client needed to review and update its technical documentation, including product masters, process flows, risk assessments, and standard operating procedures (SOPs).

Additionally, the company required support in:

• Identifying and prioritizing risks associated with process and equipment changes.
• Investigating deviations and defining corrective and preventive actions (CAPA).
• Assessing and improving its aseptic manufacturing process to align with Annex 1 of the EU GMP guidelines for sterile medicinal products.

方法

A hands-on collaboration for lasting improvements

QbD Group supported the client by prioritizing documentation updates to ensure MDR compliance, conducting root cause analyses to implement CAPA actions, and performing a gap analysis of the aseptic process against Annex 1 requirements.

Training sessions were delivered to enhance understanding of regulatory expectations, while collaborative workshops helped define and implement quality-driven improvements.

结果

Measurable impact and long-term benefits

By leveraging QbD Group’s expertise, the client successfully enhanced regulatory compliance and strengthened its aseptic manufacturing processes.

Our collaboration resulted in:

• Updated technical documentation and new risk assessments aligned with MDR timelines.
• A structured project plan for aseptic process improvements, ensuring long-term regulatory readiness.
• Implementation of key mid-term actions, including:
  • Enhanced aseptic interventions and operator behavior.
  • Risk mitigation strategies and contingency planning.
  • Introduction of new aseptic tools to optimize sterility assurance.
• Increased awareness and expertise among employees in aseptic manufacturing, reinforcing a culture of continuous improvement and compliance.